Panacea Biotec Limited (PANACEABIO.BO)

INR 432.15

(4.99%)

Total Debt Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual total debt in 2023 was 209.9 Million INR , up 3.81% from previous year.
Panacea Biotec Limited's latest quarterly total debt in 2023 FY was 209.9 Million INR , up 3.81% from previous quarter.
Panacea Biotec Limited reported annual total debt of 202.19 Million INR in 2022, down -40.8% from previous year.
Panacea Biotec Limited reported annual total debt of 341.55 Million INR in 2021, down -95.83% from previous year.
Panacea Biotec Limited reported quarterly total debt of - INR for 2023 Q1, down -100.0% from previous quarter.
Panacea Biotec Limited reported quarterly total debt of 209.9 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Total Debt of Panacea Biotec Limited (2023 - 2004)

Year	Total Debt	Total Debt Growth
2023	209.9 Million INR	3.81%
2022	202.19 Million INR	-40.8%
2021	341.55 Million INR	-95.83%
2020	8.19 Billion INR	10.42%
2019	7.42 Billion INR	14.8%
2018	6.46 Billion INR	-31.28%
2017	9.4 Billion INR	-5.32%
2016	9.93 Billion INR	-0.34%
2015	9.96 Billion INR	-2.14%
2014	10.18 Billion INR	12.72%
2013	9.03 Billion INR	-6.23%
2012	9.63 Billion INR	26.49%
2011	7.62 Billion INR	-3.25%
2010	7.87 Billion INR	11.66%
2009	7.05 Billion INR	0.35%
2008	7.03 Billion INR	76.37%
2007	3.98 Billion INR	87.17%
2006	2.12 Billion INR	-63.67%
2005	5.86 Billion INR	263.81%
2004	1.61 Billion INR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	209.9 Million INR	3.81%
2023 Q1	- INR	-100.0%
2023 Q4	209.9 Million INR	0.0%
2023 Q2	206.8 Million INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	323.3 Million INR	0.0%
2022 Q4	202.19 Million INR	0.0%
2022 FY	202.19 Million INR	-40.8%
2021 Q3	- INR	-100.0%
2021 FY	341.55 Million INR	-95.83%
2021 Q4	341.55 Million INR	0.0%
2021 Q2	8.26 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q2	6.4 Billion INR	0.0%
2020 Q4	8.19 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	8.19 Billion INR	10.42%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 FY	7.42 Billion INR	14.8%
2019 Q1	- INR	-100.0%
2019 Q2	6.58 Billion INR	0.0%
2019 Q4	7.42 Billion INR	0.0%
2018 Q4	6.46 Billion INR	0.0%
2018 FY	6.46 Billion INR	-31.28%
2017 FY	9.4 Billion INR	-5.32%
2016 FY	9.93 Billion INR	-0.34%
2015 FY	9.96 Billion INR	-2.14%
2014 FY	10.18 Billion INR	12.72%
2013 FY	9.03 Billion INR	-6.23%
2012 FY	9.63 Billion INR	26.49%
2011 FY	7.62 Billion INR	-3.25%
2010 FY	7.87 Billion INR	11.66%
2009 FY	7.05 Billion INR	0.35%
2008 FY	7.03 Billion INR	76.37%
2007 FY	3.98 Billion INR	87.17%
2006 FY	2.12 Billion INR	-63.67%
2005 FY	5.86 Billion INR	263.81%
2004 FY	1.61 Billion INR	0.0%

Peer Total Debt Comparison of Panacea Biotec Limited

Name	Total Debt	Total Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	84.526%
Biocon Limited	162.76 Billion INR	99.871%
Blue Jet Healthcare Limited	16.12 Million INR	-1201.302%
Concord Biotech Limited	97.37 Million INR	-115.556%
Dishman Carbogen Amcis Limited	23.12 Billion INR	99.092%
FERMENTA BIOTECH LIMITED	1.32 Billion INR	84.131%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	586.5 Million INR	64.211%
SAMSRITA LABS LIMITED	22.03 Million INR	-852.705%
Servoteach Industries Limited	5059.00 INR	-4148941.313%
SMS Lifesciences India Limited	1 Billion INR	79.161%
Supriya Lifescience Limited	54.88 Million INR	-282.471%
Syngene International Limited	5.55 Billion INR	96.219%
TAKE Solutions Limited	370.85 Million INR	43.4%
Titan Biotech Limited	83.02 Million INR	-152.803%
Transgene Biotek Limited	140.01 Million INR	-49.918%
Vanta Bioscience Limited	609.53 Million INR	65.564%